Yhhu3813 is a novel selective inhibitor of c-Met Kinase that inhibits c-Met-dependent neoplastic phenotypes of human cancer cells
Chang-xi He(Chinese Academy of Sciences), Meiyu Geng(Shanghai Institute of Materia Medica)
Cited by 16
Related Papers
Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer’s disease progression
|Cell Research|2019|1.1k
Structural insights into a shared mechanism of human STING activation by a potent agonist and an autoimmune disease-associated mutation
|Cell Discovery|2022|44
Marine-derived chromopeptide A, a novel class I HDAC inhibitor, suppresses human prostate cancer cell proliferation and migration
|Acta Pharmacologica Sinica|2017|30